Trying to reduce ovarian damage in patients with Hodgkin lymphoma using GnRH agonists?

Fertil Steril. 2009 Jan;91(1):298-9; author reply 299. doi: 10.1016/j.fertnstert.2008.05.011. Epub 2008 Nov 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Female
  • Fertility Agents, Female / administration & dosage
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / physiopathology
  • Humans
  • Menstrual Cycle / drug effects*
  • Pregnancy
  • Pregnancy Rate
  • Primary Ovarian Insufficiency / chemically induced
  • Primary Ovarian Insufficiency / prevention & control*
  • Treatment Outcome
  • Triptorelin Pamoate / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Fertility Agents, Female
  • Triptorelin Pamoate